Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Doxylamine succinate
Cat. No.:
OB0225LY-0116
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Doxylamine succinate is a histamine H1 antagonist that has sedative and anti-allergic properties.
Synonym:
Decapryn; 562-10-7; 2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate; Butanedioic acid, N, N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine; alpha-(2-Dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline acid succinate; Ethanamine, N, N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, butanedioate (1:1); N, N-Dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine succinate
CAS No.:
562-10-7
Compound CID:
11224
Formula:
C21H28N2O5
Formula Weight:
388.46
Specification
Relative Density:
1.043 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Doxylamine succinate can be used to study allergic rhinitis, insomnia and colds and develop novel drugs.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Immunology/Inflammation; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
d9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
100 mg/mL; 257.43 mM
Water Max Solubility:
100 mg/mL; 257.43 mM
